Search

everythinglearnresearchcommunity

for

Search:↓

Fucoidan may help regrow hair and reduce inflammation in hair loss.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Phenoxyethanol in hair growth products may be linked to frontal fibrosing alopecia.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

FLRG and follistatin have different roles in wound healing.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Adding the topical gel improved hair growth more than using minoxidil or finasteride alone.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.

Intralesional betamethasone and oral hydroxychloroquine improved hair loss in a woman with frontal fibrosing alopecia.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

bFGF delays hair growth in mice.

Mutating the gmds gene in zebrafish increases hair cell numbers and regeneration.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Sunscreen use is linked to frontal fibrosing alopecia, especially in males.

Researchers identified a new variant of the FGF5 gene in sheep that affects hair length.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Prostaglandin F2α may help treat hair loss by promoting hair growth.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

GLI2 increases follistatin production in human skin cells.

FGF18 helps hair follicles resist radiation by stopping hair growth cycles.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Frontal fibrosing alopecia causes hair loss along the frontal hairline, mainly in postmenopausal women, and needs better treatments.

2′‐Fucosyllactose reduces hair loss and promotes hair growth in mice.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.